{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:21:50Z","timestamp":1777519310086,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche ForschungsGemeinschaft","doi-asserted-by":"crossref","award":["GZ:MO 1071\/12-1 AOBJ: 620617"],"award-info":[{"award-number":["GZ:MO 1071\/12-1 AOBJ: 620617"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sub-Saharan Africa carries most of the global burden of schistosomiasis. To optimize disease control and reduce morbidity, precise data are needed for control measures adapted to the local epidemiological situation. The objective of this study is to provide baseline information on schistosomiasis dynamics, including praziquantel (PZQ) treatment outcome in children and young adults living in the vicinity of Lambar\u00e9n\u00e9, Gabon.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Eligible volunteers were included into a prospective longitudinal study. Urine filtration technique was used to detect eggs in urine for schistosomiasis diagnosis. Subjects were treated with 60 mg of PZQ once per month for three consecutive months, and the outcome was assessed by cure rate (CR) and egg reduction rate (ERR).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 328 volunteers were enrolled in the study with a mean (\u00b1\u2009SD) age of 12.2\u2009\u00b1\u20094.7 years-old. The female-to-male ratio was 0.99. Out of 258 participants in total, 45% had schistosomiasis during the survey and 43% presented with heavy infections. The incidences of haematuria and schistosomiasis were 0.11 and 0.17 person-years, respectively. After the first and third dose of PZQ, overall ERR of 93% and 95% were found, respectively; while the CR were 78% and 88%, respectively. Both ERR (100 <jats:italic>vs<\/jats:italic> 88%) and CR (90 <jats:italic>vs<\/jats:italic> 68%) were higher among females than males after the first dose. The CR increased for both groups after the third dose to 95% and 80%, respectively. After the first PZQ dose, ERR was higher for heavy compared to light infections (94 <jats:italic>vs<\/jats:italic> 89%), while the CR was higher for light than for heavy infections (87 <jats:italic>vs<\/jats:italic> 59%). After the third PZQ dose, ERR increased only for light infections to 99%, while CR increased to 98% and 75% for light and for heavy infections, respectively. The reinfection rate assessed at a mean of 44.6 weeks post-treatment was 25%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The prevalence of schistosomiasis is moderate in communities living in the vicinity of Lambar\u00e9n\u00e9, where a subpopulation with a high risk of reinfection bears most of the burden of the disease. To improve schistosomiasis control in this scenario, we suggest education of these high-risk groups to seek themselves a one-year PZQ treatment.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic> clinicaltrials.gov Identifier NCT 02769103. Registered 11 May 2016, retrospectively registered. <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02769013\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02769013<\/jats:ext-link><\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13071-019-3836-6","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T15:04:49Z","timestamp":1575990289000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon"],"prefix":"10.1186","volume":"12","clinical-trial-number":[{"clinical-trial-number":"nct02769013","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3816-998X","authenticated-orcid":false,"given":"Jean Claude","family":"Dejon-Agob\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Ronald","family":"Edoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yabo Josiane","family":"Honkpehedji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannot Fr\u00e9jus","family":"Zinsou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bayod\u00e9 Rom\u00e9o","family":"Ad\u00e9gbit\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirabeau Mbong","family":"Ngwese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ance","family":"Mangaboula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Lell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamirat Gebru","family":"Woldearegai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin Peter","family":"Grobusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Mordm\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u00f4la Akim","family":"Adegnika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,10]]},"reference":[{"key":"3836_CR1","unstructured":"CDC. Schistosomiasis. 2018. https:\/\/www.cdc.gov\/parasites\/schistosomiasis\/index.html. Accessed 14 Jul 2018."},{"key":"3836_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0001-706X(00)00122-4","volume":"77","author":"L Chitsulo","year":"2000","unstructured":"Chitsulo L, Engels D, Montresor A, Savioli L. The global status of schistosomiasis and its control. Acta Trop. 2000;77:41\u201351.","journal-title":"Acta Trop."},{"key":"3836_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40249-017-0293-3","volume":"6","author":"M Kabuyaya","year":"2017","unstructured":"Kabuyaya M, Chimbari MJ, Manyangadze T, Mukaratirwa S. Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa. Infect Dis Poverty. 2017;6:83.","journal-title":"Infect Dis Poverty."},{"key":"3836_CR4","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1046\/j.1365-3156.2001.00785.x","volume":"6","author":"EK N\u2019Goran","year":"2001","unstructured":"N\u2019Goran EK, Utzinger J, N\u2019Guessan AN, M\u00fcller I, Zambl\u00e9 K, Lohourignon KL, et al. Reinfection with Schistosoma haematobium following school-based chemotherapy with praziquantel in four highly endemic villages in C\u00f4te d\u2019Ivoire. Trop Med Int Health. 2001;6:817\u201325.","journal-title":"Trop Med Int Health."},{"key":"3836_CR5","unstructured":"WHO. Fact sheet; schistosomiasis. Geneva: World Health Organization; 2018. http:\/\/www.who.int\/news-room\/fact-sheets\/detail\/schistosomiasis. Accessed 14 Jul 2018."},{"key":"3836_CR6","unstructured":"WHO. Schistosomiasis strategy. Geneva: World Health Organization; 2018. http:\/\/www.who.int\/schistosomiasis\/strategy\/en\/. Accessed 14 Jul 2018."},{"key":"3836_CR7","unstructured":"WHO. Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee. Geneva: World Health Organization; 2002. http:\/\/apps.who.int\/iris\/handle\/10665\/42588. Accessed 26 Jun 2018."},{"key":"3836_CR8","unstructured":"WHO. WHO model prescribing information. Drugs used in parasitic diseases, second edition. Geneva: World Health Organization; 1995. http:\/\/apps.who.int\/medicinedocs\/en\/d\/Jh2922e\/3.7.3.html. Accessed 14 Jul 2018."},{"key":"3836_CR9","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1056\/NEJMra012396","volume":"346","author":"AGP Ross","year":"2002","unstructured":"Ross AGP, Bartley PB, Sleigh AC, Olds GR, Li Y, Williams GM, et al. Schistosomiasis. N Engl J Med. 2002;346:1212\u201320.","journal-title":"N Engl J Med."},{"key":"3836_CR10","unstructured":"WHO. The selection and use of essential medicines. Report of the WHO Expert Committee; including the 20th WHO model list of essential medicines and the 6th WHO model list of essential medicines for children. Report No.: 1006. Geneva: World Health Organization; 2017. https:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/EML_2017_EC21_Unedited_Full_Report.pdf. Accessed 14 Jul 2018."},{"key":"3836_CR11","unstructured":"WHO. WHO drug information. Vol. 14. Geneva: World Health Organisation; 2000. p. 143. http:\/\/apps.who.int\/medicinedocs\/pdf\/h1463e\/h1463e.pdf. Accessed 30 Jan 2019."},{"key":"3836_CR12","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/S0140-6736(00)02114-0","volume":"355","author":"J Utzinger","year":"2000","unstructured":"Utzinger J, N\u2019Goran EK, N\u2019Dri A, Lengeler C, Xiao S, Tanner M. Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial. Lancet. 2000;355:1320\u20135.","journal-title":"Lancet."},{"key":"3836_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.actatropica.2016.02.015","volume":"158","author":"H Elmorshedy","year":"2016","unstructured":"Elmorshedy H, Tanner M, Bergquist RN, Sharaf S, Barakat R. Prophylactic effect of artemether on human schistosomiasis mansoni among Egyptian children: a randomized controlled trial. Acta Trop. 2016;158:52\u20138.","journal-title":"Acta Trop."},{"key":"3836_CR14","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1086\/324004","volume":"184","author":"S Borrmann","year":"2001","unstructured":"Borrmann S, Szlez\u00e1k N, Faucher JF, Matsiegui PB, Neubauer R, Binder RK, et al. Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study. J Infect Dis. 2001;184:1363\u20136.","journal-title":"J Infect Dis."},{"key":"3836_CR15","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1007\/s00436-013-3559-0","volume":"112","author":"S Xiao","year":"2013","unstructured":"Xiao S. Mefloquine, a new type of compound against schistosomes and other helminthes in experimental studies. Parasitol Res. 2013;112:3723\u201340.","journal-title":"Parasitol Res."},{"key":"3836_CR16","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1093\/cid\/cis976","volume":"56","author":"A Basra","year":"2013","unstructured":"Basra A, Mombo-Ngoma G, Melser MC, Diop DA, W\u00fcrbel H, Mackanga JR, et al. Efficacy of mefloquine intermittent preventive treatment in pregnancy against Schistosoma haematobium infection in Gabon: a nested randomized controlled assessor-blinded clinical trial. Clin Infect Dis. 2013;56:e68\u201375.","journal-title":"Clin Infect Dis."},{"key":"3836_CR17","unstructured":"Pilon S. Essential drugs. Practical guide intended for physicians, pharmacists, nurses and medical auxiliaries. M\u00e9decins Sans Fronti\u00e8res; 2016. http:\/\/refbooks.msf.org\/msf_docs\/en\/essential_drugs\/ed_en.pdf. Accessed 14 Jul 2018."},{"key":"3836_CR18","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/S0035-9203(01)90034-3","volume":"95","author":"A Montresor","year":"2001","unstructured":"Montresor A, Engels D, Chitsulo L, Bundy DA, Brooker S, Savioli L. Development and validation of a \u2018tablet pole\u2019 for the administration of praziquantel in sub-Saharan Africa. Trans R Soc Trop Med Hyg. 2001;95:542\u20134.","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"3836_CR19","unstructured":"WHO. Assessing the efficacy of anthelminthic drugs against schistosomiasis and soil-transmitted helminthiases. Geneva: World Health Organization; 2013. http:\/\/www.who.int\/intestinal_worms\/resources\/9789241564557\/en\/. Accessed 11 Jun 2018."},{"key":"3836_CR20","doi-asserted-by":"publisher","first-page":"394","DOI":"10.4269\/ajtmh.15-0703","volume":"95","author":"U Ateba-Ngoa","year":"2016","unstructured":"Ateba-Ngoa U, Jones S, Zinsou JF, Honkpehedji J, Adegnika AA, Agobe JCD, et al. Associations between helminth infections, Plasmodium falciparum parasite carriage and antibody responses to sexual and asexual stage malarial antigens. Am J Trop Med Hyg. 2016;95:394\u2013400.","journal-title":"Am J Trop Med Hyg."},{"key":"3836_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ijpara.2016.11.001","volume":"47","author":"G Mombo-Ngoma","year":"2017","unstructured":"Mombo-Ngoma G, Honkpehedji J, Basra A, Mackanga JR, Zoleko RM, Zinsou J, et al. Urogenital schistosomiasis during pregnancy is associated with low birth weight delivery: analysis of a prospective cohort of pregnant women and their offspring in Gabon. Int J Parasitol. 2017;47:69\u201374.","journal-title":"Int J Parasitol."},{"key":"3836_CR22","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/2193-1801-3-388","volume":"3","author":"U Ateba Ngoa","year":"2014","unstructured":"Ateba Ngoa U, Zinsou JF, Kassa RFK, Ngoune Feugap E, Honkpehedji YJ, Massinga-Loembe M, et al. Assessment of the effect of Schistosoma haematobium co infection on malaria parasites and immune responses in rural populations in Gabon: study protocol. SpringerPlus. 2014;3:388.","journal-title":"SpringerPlus."},{"key":"3836_CR23","doi-asserted-by":"publisher","first-page":"e0006663","DOI":"10.1371\/journal.pntd.0006663","volume":"12","author":"JC Dejon-Agob\u00e9","year":"2018","unstructured":"Dejon-Agob\u00e9 JC, Zinsou JF, Honkpehedji YJ, Ateba-Ngoa U, Edoa J-R, Adegbite BR, et al. Schistosoma haematobium effects on Plasmodium falciparum infection modified by soil-transmitted helminths in school-age children living in rural areas of Gabon. PLoS Negl Trop Dis. 2018;12:e0006663.","journal-title":"PLoS Negl Trop Dis."},{"key":"3836_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/0253-7176.116232","volume":"35","author":"J Charan","year":"2013","unstructured":"Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013;35:121\u20136.","journal-title":"Indian J Psychol Med."},{"key":"3836_CR25","unstructured":"WHO. Basic laboratory methods in medical parasitology. Geneva: World Health Organization; 1991. http:\/\/apps.who.int\/iris\/handle\/10665\/40793. Accessed 11 Jul 2018."},{"key":"3836_CR26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u201381.","journal-title":"J Biomed Inform."},{"key":"3836_CR27","doi-asserted-by":"publisher","first-page":"e2268","DOI":"10.1371\/journal.pntd.0002268","volume":"7","author":"EM Tukahebwa","year":"2013","unstructured":"Tukahebwa EM, Magnussen P, Madsen H, Kabatereine NB, Nuwaha F, Wilson S, et al. A very high infection intensity of Schistosoma mansoni in a Ugandan Lake Victoria fishing community is required for association with highly prevalent organ related morbidity. PLoS Negl Trop Dis. 2013;7:e2268.","journal-title":"PLoS Negl Trop Dis."},{"key":"3836_CR28","first-page":"1","volume":"7","author":"AY Bala","year":"2012","unstructured":"Bala AY, Ladan MU, Mainasata M. Prevalence and intensity of urinary schistosomiasis in Abarma village, Gusau, Nigeria: a preliminary investigation. Sci World J. 2012;7:1\u20134.","journal-title":"Sci World J."},{"key":"3836_CR29","doi-asserted-by":"publisher","first-page":"e1864","DOI":"10.1371\/journal.pntd.0001864","volume":"6","author":"JC Sousa-Figueiredo","year":"2012","unstructured":"Sousa-Figueiredo JC, Betson M, Atuhaire A, Arinaitwe M, Navaratnam AMD, Kabatereine NB, et al. Performance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool children. PLoS Negl Trop Dis. 2012;6:e1864.","journal-title":"PLoS Negl Trop Dis."},{"key":"3836_CR30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.actatropica.2013.06.007","volume":"128","author":"L-A Tchuem Tchuent\u00e9","year":"2013","unstructured":"Tchuem Tchuent\u00e9 L-A, Momo SC, Stothard JR, Rollinson D. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon. Acta Trop. 2013;128:275\u201383.","journal-title":"Acta Trop."},{"key":"3836_CR31","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.trstmh.2008.03.010","volume":"102","author":"N Midzi","year":"2008","unstructured":"Midzi N, Sangweme D, Zinyowera S, Mapingure MP, Brouwer KC, Kumar N, et al. Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe. Trans R Soc Trop Med Hyg. 2008;102:759\u201366.","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"3836_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0001-706X(99)00078-9","volume":"75","author":"IE Ofoezie","year":"2000","unstructured":"Ofoezie IE. Patterns of reinfection following praziquantel treatment of urinary schistosomiasis at a period of low transmission. Acta Trop. 2000;75:123\u20136.","journal-title":"Acta Trop."},{"key":"3836_CR33","doi-asserted-by":"publisher","DOI":"10.1177\/0049475518786835","author":"T Hailu","year":"2018","unstructured":"Hailu T, Abera B, Mulu W, Alemu M, Yizengaw E, Genanew A. Efficacy of single dose albendazole and praziquantel drugs among helminth-infected school children at Rural Bahir Dar, northwest Ethiopia. Trop Doct. 2018. https:\/\/doi.org\/10.1177\/0049475518786835.","journal-title":"Trop Doct."},{"key":"3836_CR34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s13071-015-0980-5","volume":"8","author":"B Senghor","year":"2015","unstructured":"Senghor B, Diaw OT, Doucoure S, Sylla SN, Seye M, Talla I, et al. Efficacy of praziquantel against urinary schistosomiasis and reinfection in Senegalese school children where there is a single well-defined transmission period. Parasit Vectors. 2015;8:362.","journal-title":"Parasit Vectors."},{"key":"3836_CR35","first-page":"1","volume":"1","author":"OE Onifade","year":"2018","unstructured":"Onifade OE, Oniya MO. Prevalence of urinary schistosomiasis and efficacy of praziquantel; a case study of school pupils in Oke-Igbo, Ondo State, Nigeria. South Asian J Parasitol. 2018;1:1\u201310.","journal-title":"South Asian J Parasitol."},{"key":"3836_CR36","doi-asserted-by":"publisher","first-page":"205031211878674","DOI":"10.1177\/2050312118786748","volume":"6","author":"J Mohammed","year":"2018","unstructured":"Mohammed J, Weldegebreal F, Teklemariam Z, Mitiku H. Clinico-epidemiology, malacology and community awareness of Schistosoma mansoni in Haradenaba and Dertoramis kebeles in Bedeno district, eastern Ethiopia. SAGE Open Med. 2018;6:2050312118786748.","journal-title":"SAGE Open Med."},{"key":"3836_CR37","doi-asserted-by":"publisher","first-page":"778","DOI":"10.4269\/ajtmh.2004.71.778","volume":"71","author":"L-AT Tchuent\u00e9","year":"2004","unstructured":"Tchuent\u00e9 L-AT, Shaw DJ, Polla L, Cioli D, Vercruysse J. Efficacy of praziquantel against Schistosoma haematobium infection in children. Am J Trop Med Hyg. 2004;71:778\u201382.","journal-title":"Am J Trop Med Hyg."},{"key":"3836_CR38","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4103\/0976-500X.162004","volume":"6","author":"J Singh","year":"2015","unstructured":"Singh J. International conference on harmonization of technical requirements for registration of pharmaceuticals for human use. J Pharmacol Pharmacother. 2015;6:185\u20137.","journal-title":"J Pharmacol Pharmacother."},{"key":"3836_CR39","unstructured":"World Medical Association. The World Medical Association-Declaration of Helsinki. 2013. https:\/\/www.wma.net\/what-we-do\/medical-ethics\/declaration-of-helsinki\/. Accessed 10 Jul 2019."}],"updated-by":[{"DOI":"10.1186\/s13071-021-04815-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000}}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-019-3836-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-019-3836-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-019-3836-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T16:52:42Z","timestamp":1628614362000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-019-3836-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3836"],"URL":"https:\/\/doi.org\/10.1186\/s13071-019-3836-6","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s13071-021-04815-1","asserted-by":"object"}]},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"23 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Following publication of the article, it was brought to our attention that Tamirat Gebru Woldearegai had been erroneously omitted from the author list; the article has since been corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2021","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13071-021-04815-1","URL":"https:\/\/doi.org\/10.1186\/s13071-021-04815-1","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original study was approved by the institutional ethics committee of CERMEL, Lambar\u00e9n\u00e9, Gabon (Reference number: CEI-CERMEL 009\/2014). For this analysis, no additional intervention was made. The study was conducted in line with the Good Clinical Practice (GCP) principles of the International Conference on Harmonization (ICH) [] and the Declaration of Helsinki [].","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"577"}}